share_log

Enovis (NYSE:ENOV Shareholders Incur Further Losses as Stock Declines 8.3% This Week, Taking Three-year Losses to 30%

Enovis (NYSE:ENOV Shareholders Incur Further Losses as Stock Declines 8.3% This Week, Taking Three-year Losses to 30%

Enovis(紐約證券交易所代碼:ENOV)股東蒙受進一步損失,本週股價下跌8.3%,使三年跌幅達到30%
Simply Wall St ·  05/06 10:35

For many investors, the main point of stock picking is to generate higher returns than the overall market. But its virtually certain that sometimes you will buy stocks that fall short of the market average returns. Unfortunately, that's been the case for longer term Enovis Corporation (NYSE:ENOV) shareholders, since the share price is down 60% in the last three years, falling well short of the market return of around 17%. Even worse, it's down 15% in about a month, which isn't fun at all. Importantly, this could be a market reaction to the recently released financial results. You can check out the latest numbers in our company report.

對於許多投資者來說,選股的要點是產生比整個市場更高的回報。但幾乎可以肯定的是,有時候你會買入低於市場平均回報率的股票。不幸的是,Enovis Corporation(紐約證券交易所代碼:ENOV)的長期股東就是這種情況,因爲股價在過去三年中下跌了60%,遠低於17%左右的市場回報率。更糟糕的是,它在大約一個月內下降了15%,這一點都不好玩。重要的是,這可能是市場對最近公佈的財務業績的反應。你可以在我們的公司報告中查看最新的數字。

After losing 8.3% this past week, it's worth investigating the company's fundamentals to see what we can infer from past performance.

在上週下跌8.3%之後,值得調查該公司的基本面,以了解我們可以從過去的表現中推斷出什麼。

Enovis isn't currently profitable, so most analysts would look to revenue growth to get an idea of how fast the underlying business is growing. When a company doesn't make profits, we'd generally hope to see good revenue growth. That's because it's hard to be confident a company will be sustainable if revenue growth is negligible, and it never makes a profit.

Enovis目前沒有盈利,因此大多數分析師會着眼於收入的增長,以了解基礎業務的增長速度。當一家公司沒有盈利時,我們通常希望看到良好的收入增長。那是因爲如果收入增長可以忽略不計,而且從來沒有盈利,就很難確信一家公司能否實現可持續發展。

In the last three years Enovis saw its revenue shrink by 9.3% per year. That is not a good result. The share price decline of 17% compound, over three years, is understandable given the company doesn't have profits to boast of, and revenue is moving in the wrong direction. Having said that, if growth is coming in the future, now may be the low ebb for the company. We'd be pretty wary of this one until it makes a profit, because we don't specialize in finding turnaround situations.

在過去的三年中,Enovis的收入每年減少9.3%。這不是一個好結果。鑑於該公司沒有利潤可吹噓,而且收入正朝着錯誤的方向發展,股價在三年內複合下跌了17%,這是可以理解的。話雖如此,如果未來出現增長,那麼現在可能是公司的低潮。在它盈利之前,我們會非常警惕,因爲我們不擅長尋找轉機情況。

The image below shows how earnings and revenue have tracked over time (if you click on the image you can see greater detail).

下圖顯示了收入和收入隨時間推移的跟蹤情況(如果您點擊圖片,可以看到更多細節)。

earnings-and-revenue-growth
NYSE:ENOV Earnings and Revenue Growth May 6th 2024
紐約證券交易所:ENOV收益和收入增長 2024年5月6日

Enovis is well known by investors, and plenty of clever analysts have tried to predict the future profit levels. So it makes a lot of sense to check out what analysts think Enovis will earn in the future (free analyst consensus estimates)

Enovis爲投資者所熟知,許多聰明的分析師都試圖預測未來的利潤水平。因此,看看分析師認爲Enovis將來的收入很有意義(免費的分析師共識估計)

What About The Total Shareholder Return (TSR)?

那麼股東總回報(TSR)呢?

We've already covered Enovis' share price action, but we should also mention its total shareholder return (TSR). The TSR attempts to capture the value of dividends (as if they were reinvested) as well as any spin-offs or discounted capital raisings offered to shareholders. We note that Enovis' TSR, at -30% is higher than its share price return of -60%. When you consider it hasn't been paying a dividend, this data suggests shareholders have benefitted from a spin-off, or had the opportunity to acquire attractively priced shares in a discounted capital raising.

我們已經報道了Enovis的股價走勢,但我們還應該提及其股東總回報率(TSR)。股東總回報率試圖捕捉股息(就好像它們被再投資一樣)以及向股東提供的任何分拆或折扣資本籌集的價值。我們注意到,Enovis的股東總回報率爲-30%,高於其-60%的股價回報率。當你考慮到它沒有派發股息時,這些數據表明股東已經從分拆中受益,或者有機會通過折扣融資收購定價誘人的股票。

A Different Perspective

不同的視角

While the broader market gained around 26% in the last year, Enovis shareholders lost 9.9%. Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. Longer term investors wouldn't be so upset, since they would have made 2%, each year, over five years. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. You could get a better understanding of Enovis' growth by checking out this more detailed historical graph of earnings, revenue and cash flow.

去年整體市場上漲了約26%,而Enovis的股東卻下跌了9.9%。即使是優質股票的股價有時也會下跌,但我們希望在過於感興趣之前看到企業基本指標的改善。長期投資者不會那麼沮喪,因爲他們本可以在五年內每年賺2%。最近的拋售可能是一個機會,因此可能值得查看基本面數據以尋找長期增長趨勢的跡象。通過查看這張更詳細的收益、收入和現金流歷史圖表,你可以更好地了解Enovis的增長。

We will like Enovis better if we see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

如果我們看到一些重大的內幕收購,我們會更喜歡Enovis。在我們等待的同時,請查看這份免費清單,列出了最近有大量內幕收購的成長型公司。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

請注意,本文引用的市場回報反映了目前在美國交易所交易的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論